| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778320 | European Urology | 2018 | 7 Pages |
Abstract
In this report, we looked at whether repeat prostate-specific antigen (PSA) measurements, or PSA kinetics, improve prediction of biopsy outcomes in men using active surveillance to manage localized prostate cancer. We found that in a large multicenter active surveillance cohort, PSA kinetics improves the prediction of surveillance biopsy outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Matthew R. Cooperberg, James D. Brooks, Anna V. Faino, Lisa F. Newcomb, James T. Kearns, Peter R. Carroll, Atreya Dash, Ruth Etzioni, Michael D. Fabrizio, Martin E. Gleave, Todd M. Morgan, Peter S. Nelson, Ian M. Thompson, Andrew A. Wagner,